Founded in 1966, Werfen is a worldwide developer, manufacturer and distributor of Specialized Diagnostic instruments, related reagents, automation workcells, and data management solutions for use primarily in hospitals and independent clinical laboratories. The Company’s business lines include Hemostasis, Acute Care Diagnostics, Autoimmunity, and Original Equipment Manufacturing (OEM). Werfen operates directly in more than 30 countries and in more than 100 territories through distributors.
For more information, visit werfen.com.
Founded in 1982, Immucor is a global leader in Transfusion and Transplant diagnostics, facilitating patient–donor compatibility. The Company strives to create a world where anyone, anywhere in need of a transfusion or a transplant receives the right blood or transplant that is safe, accessible, and affordable. With the right match, a life can be transformed, together. To learn more, visit www.immucor.com.
Werfen’s Hemostasis portfolio includes ACL TOP® Family 50 Series and ACL TOP Family Hemostasis Testing Systems, ACL AcuStar® system, ACL Elite® systems, HemoCell® Specialized Lab Automation, HemoHub® Intelligent Data Manager, along with the comprehensive line of HemosIL® assays.
The Acute Care portfolio includes the GEM® Premier™ 5000 system with Intelligent Quality Management 2 (iQM®2), GEM Premier 3500 system, GEM Premier ChemSTAT™ system, GEMweb® Plus Custom Connectivity, ROTEM® viscoelastic testing systems, Hemochron™ systems, VerifyNow™ platelet-function testing system, and Avoximeter™ CO-Oximeters.
The Autoimmunity portfolio includes Aptiva®, BIO-FLASH®, NOVA View, AUTOLoader and QUANTA-Lyser 3000 systems, and QUANTA Link data management solutions.
The Transfusion and Transplant portfolio includes the Echo Lumena®, Neo Iris®, Capture® Workstation systems, LIFECODES® assays, and ImmuLINK® Data Management solution.